Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Perry

Gynecology Atlanta, GA Medical Doctor

NPI 1588761449 CMS profile 298505

842 North Highland Ave Ne, Suite 250, Atlanta, GA 30306

Open in the dashboard

General payments

$4,322

232 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Perry of Atlanta, GA is reported in the CMS Open Payments database as having received $4,322 across 232 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 84th percentile of Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $266 14
2024 General $374 18
2023 General $727 37
2022 General $883 45
2021 General $863 41
2020 General $640 37
2019 General $568 40

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Perry
  • Gynecology median
  • Middle half of Gynecology
  • National median

In program year 2025, general payments to Michael Perry were reported at $266. Among 1,279 Gynecology profiles paid that year, the median was $162 and the middle half received between $56 and $501.

Show as a table
Year Michael Perry Gynecology median Middle half National median
2019 $568 $199 $66–$472 $163
2020 $640 $114 $42–$287 $114
2021 $863 $141 $42–$430 $132
2022 $883 $173 $52–$532 $149
2023 $727 $170 $57–$501 $160
2024 $374 $157 $50–$424 $164
2025 $266 $162 $56–$501 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Lupin Inc. $671 48 payments
  2. AbbVie, Inc. $508 26 payments
  3. Evofem Biosciences, Inc. $465 26 payments
  4. Bayer HealthCare Pharmaceuticals Inc. $424 23 payments
  5. Mayne Pharma Inc. $359 13 payments
  6. Exeltis, USA Inc. $324 16 payments
  7. TherapeuticsMD, Inc. $216 12 payments
  8. SCYNEXIS, Inc. $208 11 payments
  9. CooperSurgical, Inc. $181 9 payments
  10. Agile Therapeutics, Inc. $164 8 payments
  11. Other $801 40 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,322 232 payments
Products named General payments · program years 2019–2025
  1. SOLOSEC $497 36 payments
  2. LO LOESTRIN FE $473 24 payments
  3. Phexxi $346 18 payments
  4. Kyleena $280 15 payments
  5. Mirena Women's Health $280 15 payments
  6. MYFEMBREE $204 11 payments
  7. SLYND $167 8 payments
  8. Twirla $164 8 payments
  9. ANNOVERA $144 8 payments
  10. Mirena Womens Health $143 8 payments
  11. Other $1,960 102 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

232 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Gynecology in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record